|
2004 Conference Publication Safety of drotrecogin alfa (activated): Results of Xeus, a prospective multicenter observational studyKaren, S, Lipsett, P, Effron, M, Rickert, T, Zeckel, M, Linde-Zwirble, W, Steingrub, J and Cheatham, M (2004). Safety of drotrecogin alfa (activated): Results of Xeus, a prospective multicenter observational study. CHEST 2004 Conference, Seattle Wa, Oct 23-28, 2004. NORTHBROOK: AMER COLL CHEST PHYSICIANS. doi: 10.1378/chest.126.4_MeetingAbstracts.724S-a |
|
2003 Conference Publication Abciximab readministration: Final results of the Reopro(fi) read ministration registryDery, JP, Braden, GA, Lincoff, AM, Kereiakes, DJ, Browne, KF, Little, T, George, BS, Effron, MB, Mascelli, MA, Langrall, MA, Damaraju, L, Barnathan, ES and Tcheng, JE (2003). Abciximab readministration: Final results of the Reopro(fi) read ministration registry. 52nd Annual Scientific Session of the American-College-of-Cardiology, Chicago Illinois, Mar 30-Apr 02, 2003. NEW YORK: ELSEVIER SCIENCE INC. |
|
2003 Conference Publication Benefits and risks of abciximab use in primary Angioplasty for acute myocardial infarction: The CADILLAC trialKandzari, DE, Tcheng, JE, Grines, CL, Effron, M, Cox, DA, Garcia, E, Griffin, JJ, Guagliumi, G, Stuckey, TD, Turco, M, Lansky, AJ, Mehran, R and Stone, GW (2003). Benefits and risks of abciximab use in primary Angioplasty for acute myocardial infarction: The CADILLAC trial. 52nd Annual Scientific Session of the American-College-of-Cardiology, Chicago Illinois, Mar 30-Apr 02, 2003. NEW YORK: ELSEVIER SCIENCE INC. |
|
2003 Conference Publication Safety of an early discharge strategy following primary intervention with adjunctive glycoprotein IIb/IIIa inhibition: The CADILLAC trialKandzari, DE, Tcheng, JE, Grines, CL, Cohen, DJ, Bakhai, A, Cox, DA, Stuckey, TD, Effron, M, Griffin, JJ, Turco, M, Carroll, JD, Fahy, M, Mehran, R and Stone, GW (2003). Safety of an early discharge strategy following primary intervention with adjunctive glycoprotein IIb/IIIa inhibition: The CADILLAC trial. 52nd Annual Scientific Session of the American-College-of-Cardiology, Chicago Illinois, Mar 30-Apr 02, 2003. NEW YORK: ELSEVIER SCIENCE INC. |
|
2002 Conference Publication Tadalafil does not affect time to ischemia during exercise stress testing in patients with coronary artery diseasePatterson, D, MacDonald, TM, Effron, MB, Emmick, JT, Mitchell, MI and Kloner, RA (2002). Tadalafil does not affect time to ischemia during exercise stress testing in patients with coronary artery disease. American-Heart-Association Abstracts From Scientific Sessions, Chicago Illinois, Nov 17-20, 2002. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2002 Conference Publication Cost-effectiveness of coronary stenting and abciximab for patients with AMI: Results from the CADILLAC trialBakhai, A, Stone, GW, Murphy, SA, Githiora, L, Berezin, RH, Gedney, S, Hormel, P, Effron, M, Cox, DA, Tcheng, JE, Grines, CL and Cohen, DJ (2002). Cost-effectiveness of coronary stenting and abciximab for patients with AMI: Results from the CADILLAC trial. American-Heart-Association Abstracts From Scientific Sessions, Chicago Illinois, Nov 17-20, 2002. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2001 Conference Publication A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical dataKennedy, JS, Bymaster, FP, Schuh, L, Calligaro, DO, Nomikos, G, Felder, CC, Bernauer, M, Kinon, BJ, Baker, RW, Hay, D, Roth, HJ, Dossenbach, M, Kaiser, C, Beasley, CM, Holcombe, JH, Effron, MB and Breier, A (2001). A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data. Symposium on Management of Psychoses in Older People, Barcelona Spain, Nov, 2000. W SUSSEX: JOHN WILEY & SONS LTD. doi: 10.1002/1099-1166(200112)16:1+3.0.CO;2-5 |
|
2001 Conference Publication Abciximab readministration - Results of the ReoPro readministration registryTcheng, JE, Kereiakes, DJ, Lincoff, AM, George, BS, Kleiman, NS, Sane, DC, Cines, DB, Jordan, RE, Mascelli, MA, Langrall, MA, Damaraju, L, Schantz, A, Effron, MB and Braden, GA (2001). Abciximab readministration - Results of the ReoPro readministration registry. 71st Scientific Session of the American-Heart-Association, Dallas Tx, Nov 08-12, 1998. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. doi: 10.1161/hc3301.094533 |
|
2001 Conference Publication Abciximab use during percutaneous intervention in patients with acute myocardial infarction improves early and late clinical outcomes: Final results of the CADILLAC trialTcheng, JE, Effron, M, Grines, CL, Garcia, E, Cox, D, Stuckey, T, Carroll, J, Guagliumi, G, Rutherford, B, Lansky, AJ, Esente, P, Griffin, J and Stone, GW (2001). Abciximab use during percutaneous intervention in patients with acute myocardial infarction improves early and late clinical outcomes: Final results of the CADILLAC trial. NEW YORK: ELSEVIER SCIENCE INC. |
|
2001 Conference Publication A prospective, multicenter, international randomized trial comparing four reperfusion strategies in acute myocardial infarction: Principal report of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialStone, GW, Grines, CL, Cox, DA, Garcia, E, Tcheng, JE, Stuckey, T, Carroll, J, Guagliumi, G, Rutherford, B, Johnson, G, Effron, M, Esente, P, Lansky, AJ and Griffin, J (2001). A prospective, multicenter, international randomized trial comparing four reperfusion strategies in acute myocardial infarction: Principal report of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. NEW YORK: ELSEVIER SCIENCE INC. |
|
2000 Conference Publication Abciximab improves outcomes in patients of all ages: Pooled analysis of 4 phase 3 trialsEffron, MB, Booth, J, Balog, C and Cabot, C (2000). Abciximab improves outcomes in patients of all ages: Pooled analysis of 4 phase 3 trials. NEW YORK: EXCERPTA MEDICA INC. |
|
2000 Conference Publication Comparison of GP IIb/IIIa receptor inhibitors in patients undergoing percutaneous coronary interventions: a meta-analysisChadbourne, EB, Allen, IE, Luo, D, Gordon, MJ, Reid, P, Wilson, MG, Effron, MB, Perkins, LE, Jamal, HH and Ross, SD (2000). Comparison of GP IIb/IIIa receptor inhibitors in patients undergoing percutaneous coronary interventions: a meta-analysis. LONDON: W B SAUNDERS CO LTD. |
|
1999 Conference Publication Abciximab markedly reduces 30-day adverse outcomes in black patients undergoing coronary interventionMarks, DS, Effron, MB, Mensah, GA, Fitzpatrick, SE, Tcheng, JE and Kereiakes, DF (1999). Abciximab markedly reduces 30-day adverse outcomes in black patients undergoing coronary intervention. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
1998 Conference Publication Abciximab accelerates the reperfusion process after primary angioplasty for acute myocardial infarction, without affecting enzymatic infarct sizeBrener, SJ, Cannata, RK and Effron, MB (1998). Abciximab accelerates the reperfusion process after primary angioplasty for acute myocardial infarction, without affecting enzymatic infarct size. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
1998 Conference Publication Safety of abciximab retreatment - Final clinical report of the ReoPro readministration registry (R-3)Tcheng, JE, Kereiakes, DJ, Braden, GA, Lincoff, AM, Mascelli, MA, Langrall, MA, Damaraju, LV, Schantz, AR, Barnathan, ES and Effron, MB (1998). Safety of abciximab retreatment - Final clinical report of the ReoPro readministration registry (R-3). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
1998 Conference Publication Critical effect of timing of abciximab bolus relative to first balloon inflation in primary angioplasty. The RAPPORT trialBrener, SJ, Cannata, RK, Effron, MB and Topol, NJ (1998). Critical effect of timing of abciximab bolus relative to first balloon inflation in primary angioplasty. The RAPPORT trial. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
1998 Conference Publication Provisional stenting improves outcome of primary angioplasty independently of the use of Abciximab. The RAPPORT trialBrener, SJ, Barr, LA, Burcehnal, JEB, Katz, S and Effron, MB (1998). Provisional stenting improves outcome of primary angioplasty independently of the use of Abciximab. The RAPPORT trial. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
1998 Conference Publication The effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: Results of ReoMI pilot studyMakkar, R, Goff, B, Eigler, N, Fischell, T, Barr, L, D'Haem, C, Shah, PK, Effron, MB and Litvack, F (1998). The effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: Results of ReoMI pilot study. NEW YORK: EXCERPTA MEDICA INC. |
|
1998 Conference Publication Synergy of abciximab and ticlopidine in patients undergoing intracoronary stentingKleiman, NS, Graziadei, N, Lance, E, Maresh, K, Taylor, J, Higginbotham, J, Edwards, A, Effron, MB, Mascelli, MA and Jordan, RE (1998). Synergy of abciximab and ticlopidine in patients undergoing intracoronary stenting. NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(97)84740-7 |
|
1998 Conference Publication Safety of readministration of abciximab; Interim results of the ReoPro readministration registry (R-3)Tcheng, JE, Kereiakes, DJ, George, BS, Braden, G, Langrall, MA, Zelinger, D, Jordan, R and Effron, MB (1998). Safety of readministration of abciximab; Interim results of the ReoPro readministration registry (R-3). NEW YORK: ELSEVIER SCIENCE INC. doi: 10.1016/S0735-1097(97)83944-7 |
